ZNF217 and hematopoietic and lymphoid cell neoplasm: Based on the gaps in the literature described above, the objectives of the present study are to evaluate whether the chemo-preventive properties of cucurbitacins are related to the modulation of ZNF217 expression in acute myeloid leukemia (AML) and other hematological cancer cell lines that have been shown to express ZNF217.